Albert Bourla

· tracked since May 2026
Calls
1
Win Rate
0.0%
return
-0.4%
Calls 1 1 Posts tracked · 0.0/day
Calls
7d 0
30d 0
90d 0
Best Calls
No live winners yet
Worst Calls
PFE Long -0.4%
Most Mentioned
PFE ×1
Recent Calls
PFE Long 3 months ago
Win Rate 0% Long 1 Short 0
Win Rate
7d 0%
30d 0%
90d 0%
Average Return -0.4% Long Return -0.4% Short Return -
Average Return
7d -2.2%
30d -2.9%
90d -5.4%
Loading charts...
Result
Result
Sort
Theme Stance
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
May 05
$26.45
-0.4%
Pfizer execution and pipeline drive growth
Bourla believes Pfizer's strong Q1 results reflect excellent commercial execution, and the pipeline (including acquired assets like Seagen, Biohaven, and the obesity peptide platform) will drive growth and overcome patent losses, making the company a leading industry growth company.
Pharma & Biotech
Showing 1 of 1 calls · sorted by mentions

Albert Bourla has 1 trade ideas tracked on Buzzberg across 1 tickers since May 2026. Most covered: PFE.